Support About MPSC HeRO® News References Links Contact Us

2013-Feb-12: MPSC completes first sale in the United Kingdom.

2012-Nov-29: MPSC announces that it has received a Canadian Medical Device License for its HeRO and HeRO ES Systems.

2012-Nov-8: MPSC announces that it has received CE Mark for its HeRO and HeRO ES Systems.

Come see and learn more about HeRO:

NEO 2013, Orlando, FL, February 19-24, 2013.

CAN/AAP District IX Section on Perinatal Pediatrics, Coronado, CA, March 1-3, 2013

NICU Leadership Forum, Scottsdale, AZ, April 9-13, 2013

Pediatric Academic Society, Washington, DC, May 4-7, 2013

 

Read and listen to a HeRO story from a parent from an interview on NPR.

HeRO in the News:
NICU Heart Rate Monitoring helps keep babies healthy

Medical Predictive Science Corporation (MPSC) is engaged in the development of computational diagnostic and bioinformatic technologies for the healthcare industry. Our HeRO® System represents the leading edge of what MPSC sees as a family of innovative diagnostic tools.

HeRO works in conjunction with the existing physiological monitoring system to quantify heart rate variability. Heart rate variability can be used as a measure of neonatal distress. This is achieved through the continuous collection of heart rate information and the characterization of decreased baseline variability and transient decelerations.

If you are a parent of an infant who received HeRO monitoring, we ask that you register to SHARE your experience through the March Of Dimes®.

Important safety information: HeRO is designed for neonatal patients. A low HeRO Score should never be used to deny or withhold treatment.

About MPSC | HeRO® Product Information | References Cite HeRO® | Contact Us | Legal | News | Support  | Home
© 2012. MPSC and HeRO are trademarks of Medical Predictive Science Corporation.